Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Lila Sciences
Lila Sciences

Lila Sciences

Series A

Lila builds scientific superintelligence software and autonomous laboratories for AI-driven research and experimentation.

HQ
Cambridge, MA, US
Founded
2023
Overview
Analysis
Compare
Fundraising
Employees
News

Lila develops an operating system for science that combines scientific reasoning models with autonomous AI Science Factories. Its platform generates hypotheses, designs and runs experiments, and learns from results across life science, chemistry, materials, energy, and other research domains.

The company offers Catalyst for partner access to Lila Iris and lab-as-a-service resources, and Creation campaigns that generate validated molecules, materials, protocols, data packages, and new-company opportunities. Its technology stack trains scientific agents using experimental data, verifiers, scientific tools, compute, and robotic laboratory workflows.

Lila Sciences - Products & Services

  • Creation logo

    Creation

    Creation uses Lila Iris and AI Science Factories to generate validated scientific assets and company opportunities.

    Competing Products

    Insilico Medicine logo
    Recursion Pharmaceuticals logo
  • Catalyst logo

    Catalyst

    Catalyst gives partner science teams direct platform access to Lila Iris and AI Science Factories.

    Competing Products

    Insilico Medicine logo
    Recursion Pharmaceuticals logo

Lila Sciences - Similar Companies

Insilico Medicine logo

Insilico Medicine

insilico.com

Recursion Pharmaceuticals logo

Recursion Pharmaceuticals

recursion.com

Inherent logo

Inherent

inherentlabs.ai

Fluidize logo

Fluidize

fluidize.ai

Together AI logo

Together AI

together.ai

Anthropic logo

Anthropic

anthropic.com

Blitzy logo

Blitzy

blitzy.com

Magica logo

Magica

magica.com

xAI logo

xAI

x.ai

Cognition logo

Cognition

cognition.ai

Aether AI logo

Aether AI

aetherlabs.ai

OpenAI logo

OpenAI

openai.com

Patronus AI logo

Patronus AI

patronus.ai

General Intuition logo

General Intuition

Rogo logo

Rogo

rogo.ai

Lila Sciences - Quick Facts

Who are Lila Sciences' competitors?

Companies similar to Lila Sciences include Insilico Medicine, Recursion Pharmaceuticals, Inherent and Fluidize.

When was Lila Sciences founded?

Lila Sciences was founded in 2023.

Where is Lila Sciences' headquarters located?

Lila Sciences' headquarters is located in Cambridge, MA, US.

When was Lila Sciences' last funding round?

Lila Sciences' most recent funding round was for $350M (USD) in October 2025.

How much has Lila Sciences raised to-date?

As of Oct 14, 2025, Lila Sciences has raised a total of $550M (USD).

How many employees does Lila Sciences have?

Lila Sciences has 449 employees as of Jun 26, 2026.

Lila Sciences - Classification

Industry
  • Artificial Intelligence
Ownership
  • Venture-backed private company
Technology
  • Artificial Intelligence
Model
  • AI Platform
Customer
  • Enterprise